Angle PLC – Parsortix Demonstrates High Capture Rate of CTCs
MAJOR EUROPEAN CONSORTIUM PUBLISHES RESULTS OF LARGE-SCALE INVESTIGATION DEMONSTRATING KEY ADVANTAGES OF PARSORTIX SYSTEM IN…
Month: January 2021
NLS Pharmaceutics Ltd. Announces Pricing of $20.0 Million Initial Public Offering
STANS, Switzerland – January 29 2021 – NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) (“NLS” or…
Rockley Photonics, a leading integrated silicon photonic solution provider, closes additional $65 million to accelerate growth
Oxford, UK and Pasadena, California, 29 January 2021 – Rockley Photonics, a leading integrated optics…
Nicox Amends Bond Financing Agreement with Kreos to Provide Financial Flexibility in 2021
Press Release Nicox Amends Bond Financing Agreement with Kreos to Provide Financial Flexibility in 2021…
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board Development of lead asset SPVN06 to…
Outlook Therapeutics Increases Previously Announced Bought Deal Offering of Common Stock to $35.0 Million
MONMOUTH JUNCTION, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook…
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical…
Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a…
Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020
NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced it…
Outlook Therapeutics Announces $10.0 Million Bought Deal Offering of Common Stock
MONMOUTH JUNCTION, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook…
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; January 28, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that…
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants Strong…
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
HOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing…
GENFIT Announces Two Key Appointments to the Executive Committee
Lille, France; Cambridge, MA; January 28, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Neuronetics Announces Proposed Public Offering of Common Stock
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a…
Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical…
Evelo Biosciences Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical…
22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
New space is ideally equipped and located in the heart of Buffalo’s urban renewal WILLIAMSVILLE,…